文献速递心血管乳腺MR

评估短时心脏MRI在乳腺癌心脏毒性评价中的可行性与扫描间变异性

Assessment of Feasibility and Interscan Variability of Short-time Cardiac MRI for Cardiotoxicity Evaluation in Breast Cancer.
PubMed 文献 · Radiol Cardiothorac Imaging · 2024-01-01

本研究前瞻性纳入13名健康女性对照和85名接受化疗的乳腺癌女性,在3-T扫描仪上以俯卧位外周脉搏门控行短时心脏MRI,测量心肌固有T1、细胞外容积及心室功能参数的扫描间、线圈间和观察者间可重复性。结果显示左心室功能参数扫描间可重复性极好(ICC≥0.80),固有T1和ECV在对照组及化疗组呈现良好至优秀的可重复性,提示该方案用于乳腺癌患者心脏毒性常规监测是可行的。

要点

  • 左心室功能参数扫描间可重复性极好(ICC≥0.80),左心室射血分数扫描间变异性低(对照组SEM 2.0、CoV 3.1;化疗组SEM 1.2、CoV 1.9)。
  • ECV扫描间可重复性在对照组(ICC 0.93)和远期化疗组(ICC 0.88)为优秀,在近期化疗组仅为一般(ICC 0.52)。
  • 近期化疗组中,前间隔或下间隔的固有T1和ECV扫描间重复性与变异性优于其他节段。

核心结论

  • 短时心脏MRI在心室功能和组织特征参数的扫描间、线圈间和观察者间可重复性与变异性方面表现优秀,提示该模态用于乳腺癌患者心脏毒性评价的常规监测是可行的。

研究设计与样本

  • 前瞻性研究,纳入13名健康女性对照(平均年龄52.4岁±13.2)和85名接受化疗的乳腺癌女性(平均年龄51.8岁±9.9),使用3-T扫描仪、外周脉搏门控、俯卧位行常规乳腺MRI和短时心脏MRI,采用组内相关系数(ICC)、测量标准误(SEM)或变异系数(CoV)评估可重复性与变异性。

诊断标准与关键数值

  • 左心室功能参数扫描间可重复性极好(ICC≥0.80)。
  • 左心室射血分数扫描间变异性低:对照组SEM 2.0、CoV 3.1;化疗组SEM 1.2、CoV 1.9。
  • 固有T1扫描间可重复性:对照组ICC 0.75(优秀),线圈间ICC 0.81(优秀);近期化疗组ICC 0.72(良好),远期化疗组ICC 0.73(良好)。
  • ECV扫描间可重复性:对照组ICC 0.93(优秀),远期化疗组ICC 0.88(优秀),近期化疗组ICC 0.52(一般)。
  • 固有T1和ECV的观察者间一致性在所有组中为良好至优秀。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To investigate the feasibility and interscan variability of short-time cardiac MRI protocol after chemotherapy in individuals with breast cancer. Materials and Methods A total of 13 healthy female controls (mean age, 52.4 years ± 13.2 [SD]) and 85 female participants with breast cancer (mean age, 51.8 years ± 9.9) undergoing chemotherapy prospectively underwent routine breast MRI and short-time cardiac MRI using a 3-T scanner with peripheral pulse gating in the prone position. Interscan, intercoil, and interobserver reproducibility and variability of native T1 and extracellular volume (ECV), as well as ventricular functional parameters, were measured using the intraclass correlation coefficient (ICC), standard error of measurement (SEM), or coefficient of variation (CoV). Results Left ventricular functional parameters had excellent interscan reproducibility (ICC ≥ 0.80). Left ventricular ejection fraction showed low interscan variability in control and chemotherapy participants (SEM, 2.0 and 1.2; CoV, 3.1 and 1.9, respectively). Native T1 showed excellent interscan (ICC, 0.75) and intercoil (ICC, 0.81) reproducibility in the control group and good interscan reproducibility (ICC, 0.72 and 0.73, respectively) in the participants undergoing immediate and remote chemotherapy. Interscan reproducibility for ECV was excellent in the control group and in the remote chemotherapy group (ICC, 0.93 and 0.88, respectively) and fair in the immediate chemotherapy group (ICC, 0.52). In the regional analysis, interscan repeatability and variability of native T1 and ECV were superior in the anteroseptum or inferoseptum than in other segments in the immediate chemotherapy group. Native T1 and ECV had good to excellent interobserver agreement across all groups. Conclusion Short-time cardiac MRI showed excellent results for interscan, intercoil, and interobserver reproducibility and variability for ventricular functional or tissue characterization parameters, suggesting that this modality is feasible for routine surveillance of cardiotoxicity evaluation in individuals with breast cancer. Keywords: Cardiac MRI, Heart, Cardiomyopathy ClinicalTrials.gov registration no. NCT03301389 Supplemental material is available for this article. © RSNA, 2024.

来源:Radiol Cardiothorac Imaging,查看原文。版权归原作者所有。

引用

  1. Hong YJ, Han K, Lee HJ, et al. Assessment of Feasibility and Interscan Variability of Short-time Cardiac MRI for Cardiotoxicity Evaluation in Breast Cancer. Radiol Cardiothorac Imaging. 2024. PMID: 38329404. doi:10.1148/ryct.220229

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。